Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

CNY 28.93

(-3.21%)

EBITDA Summary of Nanjing Well Pharmaceutical Group Co.,Ltd.

  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest annual EBITDA in 2023 was 209.72 Million CNY , up 8.78% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest quarterly EBITDA in 2024 Q2 was 67.94 Million CNY , up 39.87% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported an annual EBITDA of 198.28 Million CNY in 2022, up 13.37% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported an annual EBITDA of 168.58 Million CNY in 2021, up 9.9% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a quarterly EBITDA of 37.03 Million CNY for 2024 Q3, down -55.97% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a quarterly EBITDA of 44.28 Million CNY for 2024 Q1, up 2.28% from previous quarter.

Annual EBITDA Chart of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Historical Annual EBITDA of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Year EBITDA EBITDA Growth
2023 209.72 Million CNY 8.78%
2022 198.28 Million CNY 13.37%
2021 168.58 Million CNY 9.9%
2020 158.69 Million CNY -19.93%
2019 194.14 Million CNY 18.16%
2018 165.04 Million CNY 6.58%
2017 155.57 Million CNY 31.48%
2016 117.43 Million CNY 18.26%
2015 98.35 Million CNY 61.51%
2014 61.16 Million CNY 0.0%

Peer EBITDA Comparison of Nanjing Well Pharmaceutical Group Co.,Ltd.

Name EBITDA EBITDA Difference
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 23.769%
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 94.202%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 46.467%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 71.731%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 90.27%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 89.27%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 78.42%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 330.998%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY -88.511%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 69.051%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 71.78%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY -508.795%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 56.218%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 71.525%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 40.935%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 189.576%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY -12.459%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 65.905%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 86.18%
CanSino Biologics Inc. -1.64 Billion CNY 112.736%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 82.231%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 75.058%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY -72.244%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -58022.677%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 79.527%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 81.543%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 55.783%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 95.399%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 5806.417%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 73.844%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 68.364%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 21.023%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY -34.914%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 86.87%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 95.817%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 90.551%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 86.909%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 96.753%
China National Medicines Corporation Ltd. 2.82 Billion CNY 92.578%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 21.582%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY -11.889%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 94.882%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 21.336%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 96.228%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 32.367%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 39.881%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY -1093.079%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 79.642%
Guobang Pharma Ltd. 1.04 Billion CNY 79.861%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 66.881%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 75.034%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 28.186%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY -6393.385%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 80.868%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 35.964%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 60.925%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY -87.575%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 62.929%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 462.566%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 16.279%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 89.398%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY -7.33%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 78.515%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY -3.06%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 19.299%